National Axial Spondyloarthritis Society has opened applications for the fourth cohort of its quality improvement programme Aspiring to Excellence.
Aspiring to Excellence is a strategic partnership between NASS, BRITSpA, the NHS Transformation Unit and sponsoring companies AbbVie, Biogen, Lilly, Novartis and UCB.
The Aspiring to Excellence programme brings rheumatology teams together to work with experts in service improvement to collaborate on the planning and implementation of projects that will transform healthcare for people with axial SpA.
You can find out more about the programme, plus blogs from those who have taken part and a series of podcasts looking at individual projects:
https://nass.co.uk/homepage/health-professionals/aspiring-to-excellence/
You might also want to watch this video which has cohort one member, Dr Antoni Chan from
Royal Berkshire Hospital, talking about his experiences on the programme:
Visit the NASS website for details on how to apply and to download an application form:
https://nass.co.uk/news/join-our-social-movement-for-change-apply-now-for-aspiring-to-excellence/
The closing date for applications is 1 August 2023. If you would like to find out more, please contact Jill Hamilton on jill@nass.co.uk.
